Alliance for Cancer Gene Therapy 2017 Award Gala

New York, New YorkApril 19, 2017

Alliance for Cancer Gene Therapy (ACGT), the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer, recently celebrated its 16th anniversary with a Gala at The Harvard Club of New York City. Dr. John Lahey, president of Quinnipiac University, was honored with the first ever Edward Netter Award for Business and Industry for his contributions to ACGT and the community. Dr. Lahey has been a long-time ACGT Board member. Keynote speakers included ACGT research fellow Dr. Robert Vonderheide of the University of Pennsylvania, who spoke on the exciting breakthroughs using immunotherapy for the treatment of pancreatic and solid cancer tumors as well as using the opportunity to announce a breakthrough preventative cancer vaccine he and his team are currently developing. Doug Olson, one of the first three patients in the nation treated in the groundbreaking cancer immunotherapy CAR-T clinical trial developed by ACGT research fellow and Scientific Advisory Council member, Dr. Carl June, also told his compelling and moving story of being successfully treated with cancer immunotherapy treatment and how he owed his life to ACGT for funding the study. The event raised $522,000 that will go directly into funding additional cancer gene therapy research. The Alliance for Cancer Gene Therapy is headquartered in Stamford, Connecticut, and founded by Greenwich residents Barbara and Edward (1933-2011) Netter, yet its support of funding breakthrough cancer research is throughout the United States and Canada.


Order Photos